Factors associated with patient satisfaction in an outpatient hospital pharmacy

N Martínez-López-de-Castro… - European journal of …, 2018 - ejhp.bmj.com
Objective To analyse the factors leading to greater satisfaction among patients attending the
outpatient hospital pharmacy (OPh). Methods A cross-sectional study was conducted of …

Real‐world prevalence and consequences of potential drug‐drug interactions in the first‐wave COVID‐19 treatments

N Martínez‐López‐de‐Castro… - Journal of Clinical …, 2021 - Wiley Online Library
What is known and objective Initial treatment recommendations of COVID‐19 were based on
the use of antimicrobial drugs and immunomodulators. Although information on drug …

Medication persistence on biological therapies prescribed for the treatment of chronic inflammatory arthropathies: a real-world data study

M Samartín-Ucha, JM Pego-Reigosa… - European Journal of …, 2021 - ejhp.bmj.com
Objectives Medication persistence, defined as the duration of time from its initiation to its
discontinuation, is a surrogate for treatment effectiveness. The aim of the study was to …

[HTML][HTML] Adherence to biological therapies in patients with chronic inflammatory arthropathies

NML de Castro, M Álvarez-Payero… - Farmacia …, 2019 - Elsevier
Introduction The aims of the study were to quantify adherence, determine the factors that can
predict adherence and identify the consequences of poorer adherence in patients with …

[PDF][PDF] Adherencia a las terapias biológicas en pacientes con artropatías inflamatorias crónicas

N Martínez-López de Castro… - Farmacia …, 2019 - SciELO Espana
Method: A descriptive, observational and retrospective study was carried out. Patients with
rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis who started a biologic …

[PDF][PDF] Direct costs in patients with chronic inflammatory arthropathies on biological therapy: a real-world data study

N Martínez-López-de-Castro… - Clin Exp …, 2021 - clinexprheumatol.org
Direct costs in patients with chronic inflammatory arthropathies on biological therapy: a real-world
data study Page 1 Clinical and Experimental Rheumatology 2020 Clinical and Experimental …

Content analysis of Twitter in relation to biological treatments for chronic inflammatory arthropathies: an exploratory study

NML De Castro, M Samartín-Ucha… - European Journal of …, 2019 - ejhp.bmj.com
Objective To analyse the volume and content of tweets in relation to biological treatments for
chronic inflammatory arthropathies. Methods A Twitter analysis was carried out during one …

Effect of pharmacologic treatment of the nutritional status of neurologic patients

GP Corrales, CV López… - Nutrición …, 2014 - pubmed.ncbi.nlm.nih.gov
Clinical manifestations accompanying neurological diseases are diverse and affect multiple
organs. Nutritional status of patients with certain neurological diseases such as stroke …

[HTML][HTML] [Translated Article] Disease-modifying treatments for patients with multiple sclerosis in Spain

AS Pérez, SE Casado, MÁ Payero, ÁE Pueyo… - Farmacia …, 2023 - Elsevier
Multiple sclerosis is a chronic demyelinating disease of the central nervous system and long-
term disabling. Different disease-modifying treatments are available. These patients, despite …

[HTML][HTML] Biological therapy safety in chronic inflammatory arthropathy patients

N Martínez-López-de-Castro… - European journal of …, 2020 - ncbi.nlm.nih.gov
Objective The marketing of biological therapies transformed the treatment of rheumatoid
arthritis, ankylosing spondylitis and psoriatic arthritis. But there is still concern about patient …